Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Articles / May / Wake Up and Smell the Polymer
Discovery & Development Drug Delivery

Wake Up and Smell the Polymer

Caffeine isn’t just a catalyst to get you moving in the morning – it can also help create polymers for drug delivery

By Roisin McGuigan 05/09/2018 1 min read

Share

Biocompatible gels have a range of applications in the pharma industry, including drug delivery. Giovanni Traverso, assistant Professor of Medicine at Harvard Medical School and a gastroenterologist in the division of gastroenterology at Brigham and Women’s Hospital, along with his collaborators at the Massachusetts Institute of Technology, is working to develop new polymer gels with improved safety profiles. The majority of gels are created using traditional metal catalysts, which can pose a toxicity risk if any of the catalyst remains in the gel after it is formed.

In particular, Traverso and his team have hit upon a novel catalyst with low toxicity in the form of the well-loved friend of the coffee drinker: caffeine (1). “We used caffeine, a weak base, to catalyze anhydrous carboxylate ring-opening of diglycidyl-ether functionalized monomers with citric acid,” explains Traverso. The gummy polymer gels created using this method could have a range of applications, particularly for patient populations who have difficulty swallowing capsules and tablets. It’s also possible to fine-tune the properties of the gels. “We have demonstrated the capacity to tune the surface properties of these gels by recreating the surface pattern of the lotus leaf on the gels and thereby modulating the hydrophobicity of the material,” says Traverso. Altering the gels in this way could be used to impact how quickly or slowly they move through the patient’s digestive tract.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. AM DiCiccio et al., “Caffeine-catalyzed gels”, Biomaterials, 170, 127–135 (2018). PMID: 29660635.

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a Deputy Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

False

Advertisement

Recommended

False

Related Content

Managing Change in Devices for Patients
Drug Delivery
Managing Change in Devices for Patients

June 21, 2024

4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want

Dosing to Circadian Rhythm
Drug Delivery
Dosing to Circadian Rhythm

December 1, 2014

0 min read

Could medicines be made more effective with better timing?

Connecting the Dots in Drug Delivery
Drug Delivery
Connecting the Dots in Drug Delivery

December 1, 2014

0 min read

The days of “low-hanging fruit” in drug discovery are a thing of the past...

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.